Rein Therapeutics Statistics
NASDAQ: RNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.3369-0.0308 (-8.38%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Rein Therapeutics by the numbers
Rein Therapeutics has a market capitalization of $29.1 million based on 86.27M shares outstanding. With trailing EPS of $-1.51, Rein Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.3% below its 50-day average and 65.6% below its 200-day average.
Average daily trading volume is 586.68K shares, or about $197,654 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RNTX valuation vs. peer median
| Metric | RNTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $29.06M | $28.96M | +0% |
| Avg. volume | 586.68K | 115.41K | +408% |
Peer median across 8 companies: ATHE, NNVC, AYTU, NXTC, PMN, SER, EDSA, NSRX.
Valuation
- Market cap
- $29.06M
- EPS (TTM)
- $-1.51
- Shares outstanding
- 86.27M
Price and trading
- Previous close
- 0.3677
- Open
- 0.3575
- Day range
- 0.3352 – 0.3899
- 52-week range
- 0.284 – 2.10
- 52-week change
- -77.24%
- 50-day moving average
- 0.6649
- 200-day moving average
- 0.9797
- Beta
- —
- Volume
- 668.57K
- Average volume
- 586.68K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 29.06M
- Eps
- -1.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.10
- Week52 Low
- 0.28
- Avg Volume
- 586.68K
- Shares Outstanding
- 86.27M
- Ma50
- 0.66
- Ma200
- 0.98
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -83.96%
- Pct From52w Low
- 18.63%